Group One Trading
FBRX

Group One Trading’s Forte Biosciences FBRX Stock Holding History

Group One Trading’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$2.59K – 7858
2026
Q1 		$2.59K Sell
100
-200
-67% -$5.76K ﹤0.01% 6968
2025
Q4 		$8.18K Buy
300
+100
+50% +$1.75K ﹤0.01% 6923
2025
Q3 		$3K Buy
+200
New +$2.3K ﹤0.01% 7768
2024
Q1 		– Sell
-28
Closed -$575 – 7291
2023
Q4 		$575 Hold
28
– – ﹤0.01% 7073
2023
Q3 		$463 Hold
28
– – ﹤0.01% 7353
2023
Q2 		$728 Hold
28
– – ﹤0.01% 7320
2023
Q1 		$707 Sell
28
-52
-65% -$1.31K ﹤0.01% 6849
2022
Q4 		$2K Hold
80
– – ﹤0.01% 6655
2022
Q3 		$2K Hold
80
– – ﹤0.01% 7142
2022
Q2 		$3K Hold
80
– – ﹤0.01% 7284
2022
Q1 		$3K Sell
80
-360
-82% -$13.6K ﹤0.01% 7623
2021
Q4 		$24K Sell
440
-4,288
-91% -$288K ﹤0.01% 6865
2021
Q3 		$350K Buy
+4,728
New +$2.62M ﹤0.01% 4586
2020
Q2 		– Sell
-53
Closed -$24K – 5879
2020
Q1 		$24K Buy
+53
New +$20.7K ﹤0.01% 4131
2019
Q3 		– Sell
-23
Closed -$58K – 5261
2019
Q2 		$58K Buy
+23
New +$68.2K ﹤0.01% 3694
2018
Q2 		– Sell
-1
Closed -$6K – 5206
2018
Q1 		$6K Sell
1
-3
-75% -$13.9K ﹤0.01% 4466
2017
Q4 		$15K Buy
+4
New +$16K ﹤0.01% 4249

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Group One Trading's FBRX Position: Q2 2026 in Review

Group One Trading reduced its Forte Biosciences (FBRX) stake by 49% in Q2 2026, selling an estimated $2.37K and leaving 104 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #7017.

Group One Trading first reported a position in FBRX in Q4 2018 and has held it in 27 quarters since. The position peaked at $112K in Q3 2021. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Group One Trading held 104 shares of Forte Biosciences worth $2.21K as of Q2 2026.
  • Group One Trading sold 100 Forte Biosciences shares in Q2 2026, an estimated $2.37K.
  • Forte Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7017 holding.
  • Group One Trading first reported a position in Forte Biosciences in Q4 2018 and has held it in 27 quarters since.
  • Group One Trading's Forte Biosciences position peaked at $112K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.